Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.20
+0.25 (2.79%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $768.52 million as of June 9, 2026. Its market cap has increased by 77.90% in one year.
Market Cap
768.52M
Enterprise Value
1.02B
1-Year Change
77.90%
Ranking
Category
Stock Price
$9.20
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $768.52M, an increase of 7.72%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 606.35M | 21.68% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CONMED | 1.04B |
| Artivion | 989.80M |
| QuidelOrtho | 986.38M |
| InMode | 855.34M |
| Lumexa Imaging Holdings | 781.14M |
| SS Innovations International | 705.79M |
| CeriBell | 688.28M |
| SI-BONE | 663.91M |